1. Home
  2. NEPH vs VERU Comparison

NEPH vs VERU Comparison

Compare NEPH & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • VERU
  • Stock Information
  • Founded
  • NEPH 1997
  • VERU 1971
  • Country
  • NEPH United States
  • VERU United States
  • Employees
  • NEPH N/A
  • VERU N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • VERU Health Care
  • Exchange
  • NEPH Nasdaq
  • VERU Nasdaq
  • Market Cap
  • NEPH 57.2M
  • VERU 54.6M
  • IPO Year
  • NEPH 2004
  • VERU 1990
  • Fundamental
  • Price
  • NEPH $5.18
  • VERU $3.82
  • Analyst Decision
  • NEPH Strong Buy
  • VERU Strong Buy
  • Analyst Count
  • NEPH 2
  • VERU 3
  • Target Price
  • NEPH $5.50
  • VERU $33.33
  • AVG Volume (30 Days)
  • NEPH 79.5K
  • VERU 143.6K
  • Earning Date
  • NEPH 11-05-2025
  • VERU 12-15-2025
  • Dividend Yield
  • NEPH N/A
  • VERU N/A
  • EPS Growth
  • NEPH N/A
  • VERU N/A
  • EPS
  • NEPH 0.12
  • VERU N/A
  • Revenue
  • NEPH $16,684,000.00
  • VERU $16,886,419.00
  • Revenue This Year
  • NEPH $24.38
  • VERU N/A
  • Revenue Next Year
  • NEPH $10.16
  • VERU N/A
  • P/E Ratio
  • NEPH $43.88
  • VERU N/A
  • Revenue Growth
  • NEPH 21.16
  • VERU 337.24
  • 52 Week Low
  • NEPH $1.36
  • VERU $2.64
  • 52 Week High
  • NEPH $5.98
  • VERU $14.20
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 54.89
  • VERU 53.07
  • Support Level
  • NEPH $4.52
  • VERU $3.69
  • Resistance Level
  • NEPH $5.38
  • VERU $4.33
  • Average True Range (ATR)
  • NEPH 0.48
  • VERU 0.32
  • MACD
  • NEPH -0.05
  • VERU -0.08
  • Stochastic Oscillator
  • NEPH 45.21
  • VERU 33.33

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: